May IgG4-related disease be reactivated by SARS-CoV-2 infection?
Patients with inflammatory rheumatic diseases are at high risk for severe outcomes associated with coronavirus disease 2019 (COVID-19) due to the immune disturbances related to the disease, administration of immuno- suppressive drugs and comorbidities [1, 2].
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2022-05-01
|
| Series: | Rheumatology |
| Online Access: | https://www.termedia.pl/May-IgG4-related-disease-be-reactivated-by-SARS-CoV-2-infection-,18,46971,1,1.html |